
BQ-3020 TFA (143113-45-5 free base)
CAS No. ——
BQ-3020 TFA (143113-45-5 free base)( —— )
Catalog No. M30404 CAS No. ——
BQ-3020 (TFA) is a selective ETB receptor agonist that inhibits [125I] et-1 binding to the ETB receptor in the cerebellum with a 0.2nm IC50, causing vasoconstriction.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBQ-3020 TFA (143113-45-5 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBQ-3020 (TFA) is a selective ETB receptor agonist that inhibits [125I] et-1 binding to the ETB receptor in the cerebellum with a 0.2nm IC50, causing vasoconstriction.
-
DescriptionBQ-3020 (TFA) is a selective ETB receptor agonist that inhibits [125I] et-1 binding to the ETB receptor in the cerebellum with a 0.2nm IC50, causing vasoconstriction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIC50: 0.2 nM ([125I]ET-1 binding to ETB receptor)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight2120.35
-
Molecular FormulaC98H141F3N20O27S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:N-Acetyl-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Ihara M, et al. A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors. Life Sci. 1992;51(6):PL47-52.
molnova catalog



related products
-
Epigallocatechin-3-(...
(-)-Epigallocatechin-3-(3''-O-methyl) gallate is a natural product isolated from tea leaves with strong antioxidant, cytotoxic and antibacterial activity, which enhances the adhesive stability of etching rinsing adhesives to dentin.
-
Loganic acid
Loganic acid and geniposide exhibit both sides effect on superoxide generation.
-
Mahuannin B
Mahuannin B is an effective anti-hydrotic agent, inhibiting the production of cAMP via suppression of adenylate cyclase (AC) activity.